Immunomodulatory and regenerative potential of mesenchymal stem cells in recurrent aphthous stomatitis: A narrative review
RAS remains a chronic inflammatory condition without a definitive curative treatment and MSC-based therapies demonstrate promising dual immunomodulatory and regenerative potential; however, further clinical studies are required to establish safety, optimal delivery methods, and long-term efficacy.